Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05230524 · ClinicalTrials.gov registry record
DIAMOND AF Post-Approval Study
A clinical trial, sponsored by Medtronic Cardiac Ablation Solutions.
- Terminated
- Registry status
- 84
- Enrollment target
NCT05230524: Clinical Trial study, sponsored by Medtronic Cardiac Ablation Solutions.
NCT05230524 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05230524 was terminated before completion, sponsored by Medtronic Cardiac Ablation Solutions.
- TERMINATED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The DIAMOND AF Post Approval study is a prospective, global, multi-center, non-randomized, single-arm observational trial
Primary Outcome
Estimate the 36-month freedom from AF/AFL/AT recurrence following ablation procedure using the DiamondTemp™ Ablation System.
Interventions
- DEVICE DiamondTemp™ Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-02-28 |
| Est. Completion | 2025-12-17 |
Why NCT05230524 stopped before completion
NCT05230524 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which DiamondTemp™ Ablation System is the first listed.
NCT05230524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05230524 about?
NCT05230524 is a clinical study titled "DIAMOND AF Post-Approval Study". The DIAMOND AF Post Approval study is a prospective, global, multi-center, non-randomized, single-arm observational trial
What is the current status of trial NCT05230524?
This trial is currently terminated. The enrollment target is 84 participants. The study started on 2022-02-28. Estimated completion is 2025-12-17.
What interventions are being tested in trial NCT05230524?
The interventions under investigation include: DiamondTemp™ Ablation System (DEVICE).
Who is sponsoring clinical trial NCT05230524?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI